JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB39716

Anti-Hepatitis B Virus X antigen 抗体

Anti-Hepatitis B Virus X antigen antibody

3

(1 Review)

|

(40 Publications)

Anti-Hepatitis B Virus X antigen antibody (ab39716) is a rabbit polyclonal antibody detecting Hepatitis B Virus X antigen in Western Blot, IP, ELISA. Suitable for Hepatitis B virus.

- Over 30 publications
- Trusted since 2006

別名を表示する

HBV X antigen, HBx, HBxAg

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Hepatitis B virus

アプリケーション

ELISA, IP, WB

applications

特異性

The amino acid sequence of the recombinant human Hepatitis B Protein X is 100% homologous to the amino acid sequence of the natural Hepatitis B Protein X.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Hepatitis B virus": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>" } } }

製品の詳細

What is this antibody validated in?
Anti-Hepatitis B Virus X antigen antibody (ab39716) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), ELISA in Hepatitis B virus samples.

What is the molecular weight of Hepatitis B Virus X antigen?
Anti-Hepatitis B Virus X antigen (ab39716) specifically detects a band for Hepatitis B Virus X antigen (UniProt: P12936) at a molecular weight of 17kDa.

Trusted by the scientific community
Anti-Hepatitis B Virus X antigen (ab39716) was first used in a scientific publication in 2006 and has been cited over 30 times in peer-reviewed journals.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7.2 Constituents: PBS, 0.58% Sodium chloride
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Hepatitis B Virus X antigen also known as HBx protein or hepatitis X has a molecular mass of approximately 17 kDa. This antigen is expressed in liver cells or hepatocytes infected with the hepatitis B virus (HBV). HBx protein plays an important role in the replication and pathogenesis of HBV influencing the virus lifecycle and its ability to cause liver disease. Additionally anti-HBx antibodies such as 'anti HBx' and '3f6' are significant for research and diagnostic purposes due to their binding specificity.
Biological function summary

The function of HBx protein is to modulate various cellular processes to benefit the virus. HBx is not part of a larger protein complex but it interacts with host cell pathways to promote viral replication and survival. It influences transcriptional activation cell cycle progression and apoptosis. By hijacking the host cellular machinery HBx protein enhances viral replication and contributes to chronic infection.

Pathways

The activity of HBx protein impacts critical cellular signaling networks. HBx can activate the NF-kB signaling pathway which plays a role in immune response and inflammation. Additionally HBx influences the Wnt/Β-catenin signaling pathway affecting cell proliferation and differentiation. Through these pathways HBx interacts with multiple other proteins including c-Myc and p53 impacting cellular homeostasis and contributing to oncogenic potential.

HBx protein is associated with hepatitis B-related liver diseases and the development of hepatocellular carcinoma (HCC). HBx contributes significantly to the progression from chronic hepatitis B infection to liver cirrhosis and HCC. The protein affects tumor suppressors like p53 further enhancing its role in carcinogenesis. Understanding HBx’s mechanisms continues to be important for developing therapeutics and diagnostics aimed at treating HBV-related diseases.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

文献 (40)

Recent publications for all applications. Explore the full list and refine your search

Virology journal 22:189 PubMed40500754

2025

Lamin A/C promotes HBV transcription by modulating histone modification associated with cccDNA minichromosome in an HBx-dependent manner.

Applications

Unspecified application

Species

Unspecified reactive species

Linshan Jiang,Lanlang Peng,Hong Chen,Fangli Liao,Liping Yang,Yuanyuan Ye,Gaoli Zhang,Hua Sun,Qin Hu,Weixian Chen

Cancer medicine 14:e70916 PubMed40476478

2025

Hepatitis B Virus X Protein Upregulates SREBP2 to Modulate Autophagy in Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Qiuyan Lin,Yongxu Lin,Yongzhu Huang,Mingrong Wang,Xiaoxia Xie,Weiqi Cai,Qilan Guo,Pingying Jiang,Yuanlin Qi,Dan Li

Journal of biomedical science 31:34 PubMed38561844

2024

Significance of hepatitis B virus capsid dephosphorylation via polymerase.

Applications

Unspecified application

Species

Unspecified reactive species

Chih-Hsu Chang,Chiaho Shih

Journal of virology 97:e0128723 PubMed37800948

2023

Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2/ARE signaling pathway, thereby inhibiting hepatitis B virus replication.

Applications

Unspecified application

Species

Unspecified reactive species

Adi Ariffianto,Lin Deng,Takayuki Abe,Chieko Matsui,Masahiko Ito,Akihide Ryo,Hussein Hassan Aly,Koichi Watashi,Tetsuro Suzuki,Masashi Mizokami,Yoshiharu Matsuura,Ikuo Shoji

BMC cancer 23:593 PubMed37370037

2023

Integrated analysis of intratumoral biomarker and tumor-associated macrophage to improve the prognosis prediction in cancer patients.

Applications

Unspecified application

Species

Unspecified reactive species

Ming-Da Wang,Hao Xiang,Tian-Yu Hong,Abudurexiti Mierxiati,Fei-Hu Yan,Ling Zhang,Chao Wang

Frontiers in pharmacology 14:1159094 PubMed37361218

2023

Exploring the mechanism of JiGuCao capsule formula on treating hepatitis B virus infection via network pharmacology analysis and experiment verification.

Applications

Unspecified application

Species

Unspecified reactive species

Xu Cao,Ningyi Zhang,Hening Chen,Wei Wang,Yijun Liang,Jiaxin Zhang,Ruijia Liu,Shuo Li,Yuhao Yao,Qian Jin,Ziwei Guo,Yue Chen,Yuanyuan Gong,Xiaoke Li,Xiaobin Zao,Yong'an Ye

World journal of gastroenterology 28:4812-4822 PubMed36156926

2022

Previous hepatitis B viral infection-an underestimated cause of pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Sergey Batskikh,Sergey Morozov,Alexey Dorofeev,Zanna Borunova,Dmitry Kostyushev,Sergey Brezgin,Anastasiya Kostyusheva,Vladimir Chulanov

Biochemistry and biophysics reports 32:101352 PubMed36160029

2022

HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Chiyumi Oda,Kenya Kamimura,Osamu Shibata,Shinichi Morita,Yuto Tanaka,Toru Setsu,Hiroyuki Abe,Takeshi Yokoo,Akira Sakamaki,Hiroteru Kamimura,Satoshi Kofuji,Toshifumi Wakai,Hiroshi Nishina,Shuji Terai

Viruses 14: PubMed36146694

2022

HBx 128-133 Deletion Affecting HBV Mother-to-Child Transmission Weakens HBV Replication via Reducing HBx Level and CP/ENII Transcriptional Activity.

Applications

Unspecified application

Species

Unspecified reactive species

Yarong Song,Ying Lu,Yi Li,Minmin Liu,Hui Zhuang,Jie Li,Jie Wang

Cellular and molecular gastroenterology and hepatology 14:1177-1198 PubMed35987451

2022

cccDNA Surrogate MC-HBV-Based Screen Identifies Cohesin Complex as a Novel HBV Restriction Factor.

Applications

Unspecified application

Species

Unspecified reactive species

Zhuanchang Wu,Liyuan Wang,Xin Wang,Yang Sun,Haoran Li,Zhaoying Zhang,Caiyue Ren,Xiaohui Zhang,Shuangjie Li,Jinghui Lu,Leiqi Xu,Xuetian Yue,Yue Hong,Qiang Li,Haizhen Zhu,Yaoqin Gong,Chengjiang Gao,Huili Hu,Lifen Gao,Xiaohong Liang,Chunhong Ma
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com